Cargando…

Detecting EGFR Mutations in Patients with Non-small Cell Lung Cancer

Mutations in the receptor of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) are used as biomarkers for predicting the response of treatment with EGFR tyrosine kinase inhibitors (EGFR TKIs). Non-small cell lung cancer patients usually have activating EGFR mutations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hammoudeh, ZA, Antonova, O, Staneva, R, Nikolova, D, Kyuchukov, Y, Penev, A, Mintchev, T, Koleva, V, Hadjidekova, S, Toncheva, D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231315/ https://www.ncbi.nlm.nih.gov/pubmed/30425905 http://dx.doi.org/10.2478/bjmg-2018-0013

Ejemplares similares

Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations
por: Balabanski, Lubomir, et al.
Publicado: (2020)

Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental Delay
por: Mihaylova, M, et al.
Publicado: (2017)

Genome-Wide Methylation Profiling of Schizophrenia
por: Rukova, B, et al.
Publicado: (2015)

Clinical impact of copy number variation changes in bladder cancer samples
por: Spasova, Victoria, et al.
Publicado: (2021)

Whole genome methylation analyses of schizophrenia patients before and after treatment
por: Rukova, Blaga, et al.
Publicado: (2014)

Janus Kinase V617F Mutation Detection in Patients with Myelofibrosis
por: Nikolova, D, et al.
Publicado: (2019)

Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the Literature
por: Naydenov, E., et al.
Publicado: (2009)

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
por: Simonetti, Sara, et al.
Publicado: (2010)

Detection of EGFR mutations in non-small cell lung cancer by droplet digital PCR
por: Williamson, Drew F. K., et al.
Publicado: (2022)

EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups
por: Cherneva, Radostina, et al.
Publicado: (2010)

Evaluation of the Idylla ctEGFR mutation assay to detect EGFR mutations in plasma from patients with non-small cell lung cancers
por: Gilson, Pauline, et al.
Publicado: (2021)

Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology
por: Staneva, Rada, et al.
Publicado: (2013)

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations
por: Yoshimura, Akihiro, et al.
Publicado: (2018)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Optimizing adjuvant therapy in EGFR-mutated non-small cell lung cancer
por: Shepherd, Annemarie F., et al.
Publicado: (2020)

Polymorphisms, Mutations, and Amplification of the EGFR Gene in Non-Small Cell Lung Cancers
por: Nomura, Masaharu, et al.
Publicado: (2007)

Co-mutations in EGFR driven non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2019)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

How to Treat EGFR-Mutated Non–Small Cell Lung Cancer
por: Belani, Neel, et al.
Publicado: (2023)

Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
por: Lee, Seung Eun, et al.
Publicado: (2016)

Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer
por: Jiang, Guiyang, et al.
Publicado: (2013)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
por: Ali, Azhar, et al.
Publicado: (2018)

Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
por: Tanzawa, Shigeru, et al.
Publicado: (2019)

Ancient human mitochondrial genomes from Bronze Age Bulgaria: new insights into the genetic history of Thracians
por: Modi, Alessandra, et al.
Publicado: (2019)

Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
por: Rao, Ding-Yu, et al.
Publicado: (2023)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib
por: Buder, Anna, et al.
Publicado: (2020)

Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
por: Gao, Xuejuan, et al.
Publicado: (2019)

Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer
por: Sweis, Randy F, et al.
Publicado: (2016)

Postoperative management for non-small cell lung cancer harboring EGFR mutations
por: Tanaka, Fumihiro, et al.
Publicado: (2020)

Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
por: Leonetti, Alessandro, et al.
Publicado: (2019)

EGFR exon 20 insertion mutations in non-small cell lung cancer
por: Wang, Fenfang, et al.
Publicado: (2020)

Critical points in the management of EGFR-mutated non-small cell lung cancer
por: Casaluce, Francesca, et al.
Publicado: (2022)

Non-small-cell lung cancer: how to manage EGFR-mutated disease
por: Pecci, Federica, et al.
Publicado: (2022)

Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR
por: Esteva-Socias, Margalida, et al.
Publicado: (2020)

EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer
por: Phan, Thang Thanh, et al.
Publicado: (2019)

The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
por: Bai, Hao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gaj23v3qn4uoc3n5o5kgcsn437